CD8A and cancer: It enhances the anti-cancer immune response by reducing Treg cell differentiation, promoting CD8+T cell differentiation, inducing macrophages to M1-type polarization, and inhibiting the PD-1/PD-L1 immune checkpoint (Figure 2).